BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 23223433)

  • 1. The role of B7 family molecules in hematologic malignancy.
    Greaves P; Gribben JG
    Blood; 2013 Jan; 121(5):734-44. PubMed ID: 23223433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The B7 family of immune-regulatory ligands.
    Collins M; Ling V; Carreno BM
    Genome Biol; 2005; 6(6):223. PubMed ID: 15960813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment.
    Bolandi N; Derakhshani A; Hemmat N; Baghbanzadeh A; Asadzadeh Z; Afrashteh Nour M; Brunetti O; Bernardini R; Silvestris N; Baradaran B
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The B7 family revisited.
    Greenwald RJ; Freeman GJ; Sharpe AH
    Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy?
    Zhang W; Qiu Y; Xie X; Fu Y; Wang L; Cai Z
    Front Oncol; 2021; 11():647526. PubMed ID: 33869045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis.
    Qin X; Sun W; Wang C; Li M; Zhao X; Li C; Zhang H
    Reprod Biol Endocrinol; 2021 Jul; 19(1):114. PubMed ID: 34289871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New B7 Family Checkpoints in Human Cancers.
    Ni L; Dong C
    Mol Cancer Ther; 2017 Jul; 16(7):1203-1211. PubMed ID: 28679835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM; Collins M
    Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Immunity by Butyrophilins.
    Rhodes DA; Reith W; Trowsdale J
    Annu Rev Immunol; 2016 May; 34():151-72. PubMed ID: 26772212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles.
    Antohe I; Dǎscǎlescu A; Dǎnǎilǎ C; Titieanu A; Zlei M; Ivanov I; Sireteanu A; Pavel M; Cianga P
    Front Oncol; 2020; 10():264. PubMed ID: 32231996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia.
    Zong L; Zhang M; Wang W; Wan X; Yang J; Xiang Y
    Histopathology; 2019 Sep; 75(3):421-430. PubMed ID: 31013360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the B7 family of co-stimulatory molecules: successes and challenges.
    Podojil JR; Miller SD
    BioDrugs; 2013 Feb; 27(1):1-13. PubMed ID: 23329394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses.
    Ueno T; Yeung MY; McGrath M; Yang S; Zaman N; Snawder B; Padera RF; Magee CN; Gorbatov R; Hashiguchi M; Azuma M; Freeman GJ; Sayegh MH; Najafian N
    Eur J Immunol; 2012 Sep; 42(9):2343-53. PubMed ID: 22733595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting.
    Sun X; Yu Y; Ma L; Xue X; Gao Z; Ma J; Zhang M
    Invest New Drugs; 2020 Jun; 38(3):722-732. PubMed ID: 31267380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8
    Hutten TJA; Norde WJ; Woestenenk R; Wang RC; Maas F; Kester M; Falkenburg JHF; Berglund S; Luznik L; Jansen JH; Schaap N; Dolstra H; Hobo W
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):666-677. PubMed ID: 29197680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
    Butte MJ; Keir ME; Phamduy TB; Sharpe AH; Freeman GJ
    Immunity; 2007 Jul; 27(1):111-22. PubMed ID: 17629517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo.
    Zhang T; Wu MR; Sentman CL
    J Immunol; 2012 Sep; 189(5):2290-9. PubMed ID: 22851709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
    MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
    J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristic expression of B7-H3 and B7-H4 in liver biopsies from patients with HBV-related acute-on-chronic liver failure.
    Guo G; Cao D; Xu H; Ruan Z; Fei L; Xie Z; Wu Y; Chen Y
    Pathol Int; 2012 Oct; 62(10):665-74. PubMed ID: 23005593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma.
    Suvas S; Singh V; Sahdev S; Vohra H; Agrewala JN
    J Biol Chem; 2002 Mar; 277(10):7766-75. PubMed ID: 11726649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.